Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1239-2026

Siemens Medical Solutions USA, Inc recalls SOMATOM X.ceed Software applications: syngo.CT Brain Quantification syngo.CT Vessel…

Siemens Medical Solutions USA, IncMalvern, PA, United StatesReported Feb 11, 2026 · 5 months ago
Legal News Analyst ·

Reason for recall

To remove the software applications from certain CT systems as the applications have not received FDA 510(k) clearance.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

SOMATOM X.ceed Software applications: syngo.CT Brain Quantification syngo.CT Vessel Hyperdensities syngo.CT ASPECTS

Lot / code information

UDI
04056869231051
Serial #
125205, 125250

What the firm is doing

On December 19, 2025, CUSTOMER ADVISORY NOTICE letters were sent to customers. Actions to be taken: 1. Stop all use of the Applications in patient care setting. 2. Please notify and instruct all staff at your organization who need to be aware of this matter. 3. Please ensure that all users of the affected products within your organization and others who may need to be informed will receive the relevant safety information provided within this notice and will comply with the recommendations therein. 4. Please ensure that this advisory notice is retained in your product related records appropriately. Please keep this information until the corrective measures have been finalized. Actions by Siemens: Siemens Healthineers is expeditiously working to remove the Applications from your CT system(s) through a software update process. Our service organization will contact you shortly to arrange a date to perform this corrective action. Please feel free to contact our service organization at 1-800-888-7436 if you have any questions.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of Canada, Costa Rica, India, Israel.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls